We are live on
!
Find out more
AG
Artal Group Portfolio holdings
AUM
$931M
1-Year Est. Return
41.63%
This Fund
S&P 500
This Quarter
Est. Return
+5.36%
1 Year Est. Return
+41.63%
3 Year Est. Return
+181.18%
5 Year Est. Return
+113.34%
10 Year Est. Return
+1,823.73%
AUM
$3.18B
AUM Growth
–
Cap. Flow
+$2.3B
Cap. Flow
% of AUM
72.21%
Top 10 Holdings %
Top 10 Hldgs %
73.11%
Holding
88
New
88
Increased
–
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
WW
WW International
WW
|
+$1.25B |
| 2 |
Lexicon Pharmaceuticals
LXRX
|
+$550M |
| 3 |
ACOR
Acorda Therapeutics
ACOR
|
+$51.5M |
| 4 |
AUXL
AUXILIUM PHARAMCEUTICALS INC
AUXL
|
+$42.1M |
| 5 |
FURX
FURIEX PHARMACEUTICALS INC COM STK (DE)
FURX
|
+$32.1M |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 42.24% |
| 2 | Miscellaneous | 30.4% |
| 3 | Healthcare | 23.61% |
| 4 | Financials | 1.79% |
| 5 | Technology | 0.76% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
Amgen
AMGN
$203B
| $17.3M | 0.54% |
+175,000
| New | +$18.2M |
|
|
MJN
27
CALL
DELISTED
Mead Johnson Nutrition Company
MJN
| $15.8M | 0.5% |
+200,000
| New | +$16M |
|
28
CALL
Hartford Financial Services
HIG
$36.8B
| $15.5M | 0.49% |
+500,000
| New | +$14.4M |
|
|
ONIT
29
CALL
Onity Group
ONIT
$290M
| $14.4M | 0.45% |
+23,333
| New | +$14.1M |
|
|
ONIT
30
Onity Group
ONIT
$290M
| $14.4M | 0.45% |
+23,333
| New | +$14.1M |
|
31
CALL
Citigroup
C
$228B
| $14.4M | 0.45% |
+300,000
| New | +$14.4M |
|
32
CALL
Yum! Brands
YUM
$38.4B
| $13.9M | 0.44% |
+278,200
| New | +$13.8M |
|
|
ARRY
33
DELISTED
Array Biopharma Inc
ARRY
| $13.6M | 0.43% |
+3,000,000
| New | +$16.1M |
|
|
CERE
34
DELISTED
CERES, INC. COMMON STOCK NEW
CERE
| $13.1M | 0.41% |
+524,021
| New | +$10.9M |
|
|
AFFX
35
DELISTED
Affymetrix Inc
AFFX
| $12.9M | 0.41% |
+2,900,000
| New | +$11M |
|
|
AVNR
36
DELISTED
AVANIR PHARMACEUTICALS, INC CL A
AVNR
| $12.7M | 0.4% |
+2,750,000
| New | +$9.45M |
|
37
CALL
Capital One
COF
$127B
| $12.6M | 0.4% |
+200,000
| New | +$11.8M |
|
|
ESRX
38
CALL
DELISTED
Express Scripts Holding Company
ESRX
| $12.3M | 0.39% |
+200,000
| New | +$12M |
|
|
FRX
39
CALL
DELISTED
FOREST LABORATORIES INC
FRX
| $12.3M | 0.39% |
+300,000
| New | +$11.6M |
|
40
CALL
BioMarin Pharmaceuticals
BMRN
$12.5B
| $11.1M | 0.35% |
+200,000
| New | +$12.5M |
|
41
CALL
Emerson Electric
EMR
$82B
| $10.9M | 0.34% |
+200,000
| New | +$11.2M |
|
|
BRFS
42
DELISTED
BRF SA
BRFS
| $10.9M | 0.34% |
+500,000
| New | +$11.6M |
|
43
Bausch Health
BHC
$2.12B
| $10.8M | 0.34% |
+125,000
| New | +$9.85M |
|
44
iShares MSCI Mexico ETF
EWW
$1.71B
| $9.79M | 0.31% |
+150,000
| New | +$10.4M |
|
45
IQVIA
IQV
$44.4B
| $9.58M | 0.3% |
+225,000
| New | +$9.86M |
|
46
Arcos Dorados Holdings
ARCO
$1.64B
| $9.34M | 0.29% |
+822,259
| New | +$10.6M |
|
|
XOMA
47
DELISTED
Xoma
XOMA
| $9.07M | 0.29% |
+125,000
| New | +$9.3M |
|
48
American International
AIG
$39.7B
| $8.94M | 0.28% |
+200,000
| New | +$8.58M |
|
49
CALL
Wells Fargo
WFC
$271B
| $8.25M | 0.26% |
+200,000
| New | +$7.79M |
|
50
CALL
iShares MSCI Emerging Markets ETF
EEM
$30.6B
| $7.7M | 0.24% |
+200,000
| New | +$8.3M |
|
Similar funds
BCM
ACM
SAM
NS
PA
ACM
CICI
CAM
Artal Group's Q2 2013 Portfolio in Review
Q2 2013 is the first quarter with a 13F filing on record for Artal Group, which disclosed 88 positions worth $3.18B. Its ten largest holdings account for 73% of the portfolio.
Its largest position is WW International: 28,749,089 shares worth $1.32B.
By sector, the portfolio is most concentrated in Consumer Discretionary at 42% of assets, followed by Miscellaneous and Healthcare.
- Artal Group's largest Q2 2013 buy was WW International: 28,749,089 shares worth $1.32B.
- Artal Group's ten largest holdings make up 73% of its $3.18B portfolio in Q2 2013.
- Artal Group disclosed 88 positions in Q2 2013, its first 13F filing on record.
Based on Artal Group's 13F filing for Q2 2013, filed 13 Aug 2013.